A study in the December 2009 Gastroenterology looks at factors that predict response of patients with chronic hepatitis B virus (HBV) infection to therapy with pegylated interferon (PEG-IFN)–alfa. Dr. Kuemmerle speaks to study author Dr. Harry Janssen of the Department of Gastroenterology and Hepatology at the University Medical Center Rotterdam.